{"id":"https://genegraph.clinicalgenome.org/r/3170474b-3e7e-4cd0-b5f6-3542c229f63fv1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the ARSB gene and mucopolysaccharidosis type 6 (MPS6), an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of April 9, 2022. ARSB encodes aryl sulfatase B (ASB), an enzyme that catalyzes the removal of the C4 sulfate ester group from the N-acetylgalactosamine sugar residue at the nonreducing terminus of the glycosaminoglycans (GAGs) dermatan sulfate (DS) and chondroitin sulfate (CS) during lysosomal degradation (as reviewed in PMID: 17458871; PMID: 30118150). Among individuals with MPS6, ASB deficiency results in accumulation of DS and CS, which leads to symptoms including short stature, coarse facies, dysostosis multiplex, hepatosplenomegaly, corneal clouding, and cardiac disease. \n\nThe disease mechanism of MPS6 is loss of function. MPS6 was first reported in 1963 (PMID: 14091597) and the first report of biallelic variants in ARSB among patients with MPS6 was published in 1991 (PMID: 1718978). Since then, at least 201 unique variants in 478 cases have been identified (PMID: 30118150). Both case-level (genetic) and experimental evidence support the relationship between MPS6 and ARSB. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants, as well as larger deletions and duplications. In total, fourteen variants from nine probands in six publications were curated. Of note, three missense variants, c.454C>T (p.Arg152Trp), c.962T>C (p.Leu321Pro), and c.629A>G (p.Tyr210Cys), are estimated to account for 18.5% of reported cases. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between ARSB and MPS6 includes the biochemical function of the gene product (the ASB enzyme) being consistent with the clinical and biochemical findings identified individuals with MPS6 (PMID: 20385007; PMID: 4271367), the biochemical and clinical features of a feline animal model homozygous for the p.Leu476Pro variant (PMID: 8910299), and the impact of enzyme replacement therapy among human MPS6 patients (PMID: 16647419). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, ARSB is definitively associated with MPS6. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3170474b-3e7e-4cd0-b5f6-3542c229f63f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-04-17T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-07-01T00:54:59.683Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cc65731-e4b6-469d-be60-412df9733b29_proband_segregation","type":"FamilyCosegregation","dc:description":"Family has less than 3 affected individuals","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24373060","rdfs:label":"Family 12","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/6cc65731-e4b6-469d-be60-412df9733b29","type":"Family","rdfs:label":"Family 12","member":{"id":"https://genegraph.clinicalgenome.org/r/b0d7229c-8211-4ed9-be14-4fdaa77338c1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24373060","rdfs:label":"Patient 12","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9c4c1c19-d0b1-44dd-998b-5f0a9e25365d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.454C>T (p.Arg152Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA121107804"}},{"id":"https://genegraph.clinicalgenome.org/r/6bd5b849-fa49-44b9-895e-1f3567e07af1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.262C>T (p.Gln88Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559752"}}],"firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Patient 12: ASB enzyme activity 7.0 nmol/mg protein/h; uGAG 508 mg/gCr\nPatient 13: ASB enzyme activity 8.0 nmol/mg protein/h; uGAG 579 mg/gCr\n","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ac760fd2-0543-48ff-9702-710c516e5036_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24373060","allele":{"id":"https://genegraph.clinicalgenome.org/r/6bd5b849-fa49-44b9-895e-1f3567e07af1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bf615cbb-4fd1-4748-a24b-1f0ade1fee3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24373060","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c4c1c19-d0b1-44dd-998b-5f0a9e25365d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b0d7229c-8211-4ed9-be14-4fdaa77338c1"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1522f65c-6129-4c90-a9e9-54ddcecba69b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdb600d2-5012-4513-9052-b3bac823c1e4","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdb600d2-5012-4513-9052-b3bac823c1e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20143913","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b303fcc-93be-414f-b42a-3ac27b9d740b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000005.10:g.(78839427_78885583)_(78885828_78955294)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559663"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/04ab7dbb-ffb5-4549-93e9-4c3265196347","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04ab7dbb-ffb5-4549-93e9-4c3265196347_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20143913","allele":{"id":"https://genegraph.clinicalgenome.org/r/91a7301b-57cf-4fdf-bb47-ae31562e96b1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.943C>T (p.Arg315Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559828"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1522f65c-6129-4c90-a9e9-54ddcecba69b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20143913","rdfs:label":"Patient 4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/91a7301b-57cf-4fdf-bb47-ae31562e96b1"},{"id":"https://genegraph.clinicalgenome.org/r/2b303fcc-93be-414f-b42a-3ac27b9d740b"}],"detectionMethod":"Southern blotting of cDNA","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Male with severe form of MPS6, previously reported (Patient 4) in PMID: 17672828, said to have severe disease per biochemical testing including absent ASB protein by Western immunoblot","secondTestingMethod":"Other","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/04ab7dbb-ffb5-4549-93e9-4c3265196347_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cdb600d2-5012-4513-9052-b3bac823c1e4_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/2a71dd0e-c5fc-4b6b-b99d-8536c06c53a0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b25b7666-5f43-4742-830c-01165174d6b6","type":"EvidenceLine","dc:description":"Modified to 0.25 so that homozygous genotype for missense variant with functional data yields 0.5pts total ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b25b7666-5f43-4742-830c-01165174d6b6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 8116615): in LTK- cells, results in ASB activity <10% of wild-type enzyme and undetectable levels of ARSB mRNA and ASB protein ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b25b7666-5f43-4742-830c-01165174d6b6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24677745","allele":{"id":"https://genegraph.clinicalgenome.org/r/2609c1bf-c8e7-4183-be4d-bd3f5ec86630","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.962T>C (p.Leu321Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559830"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2a71dd0e-c5fc-4b6b-b99d-8536c06c53a0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24677745","rdfs:label":"Patient 4","allele":{"id":"https://genegraph.clinicalgenome.org/r/2609c1bf-c8e7-4183-be4d-bd3f5ec86630"},"detectionMethod":"PCR amplification of cDNA followed by Sanger sequencing","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"ASB enzyme activity ranges 0-30.92, all <10% versus control ASB activity","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b25b7666-5f43-4742-830c-01165174d6b6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16d83a5c-91bd-40da-87be-263020a0ac3c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6ee05cf-e062-4a06-8f3c-c2d16ee7a6ea","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6ee05cf-e062-4a06-8f3c-c2d16ee7a6ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17643332","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b303fcc-93be-414f-b42a-3ac27b9d740b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/13b6418f-5ffd-4b05-b1a3-58e4621559fc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13b6418f-5ffd-4b05-b1a3-58e4621559fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 18406185): expression in COS-7 cells, showed <6% of wild-type enzyme activity ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/13b6418f-5ffd-4b05-b1a3-58e4621559fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17643332","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2f164f8-a2f8-43dc-af53-1b1a563c3314","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.937C>G (p.Pro313Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559826"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16d83a5c-91bd-40da-87be-263020a0ac3c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17643332","rdfs:label":"Patient ML1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2b303fcc-93be-414f-b42a-3ac27b9d740b"},{"id":"https://genegraph.clinicalgenome.org/r/a2f164f8-a2f8-43dc-af53-1b1a563c3314"}],"detectionMethod":"PCR amplification of cDNA followed by sanger sequencing ","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"4y Spanish F with intermediate MPS6: ARSB activity 17% vs ctrl in leukocytes and 8% vs ctrl in fibroblasts","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/13b6418f-5ffd-4b05-b1a3-58e4621559fc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c6ee05cf-e062-4a06-8f3c-c2d16ee7a6ea_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/1129c972-7493-4ddc-a536-86a38d10bf13_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/205448fb-b63a-4c7f-b27e-32b0c5a3e5fa","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/205448fb-b63a-4c7f-b27e-32b0c5a3e5fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4fcfb7a-9b05-4e38-b70f-fb85ad55b01f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.289C>T (p.Gln97Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559762"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d8501609-f854-4f43-a51b-c6adf8126806","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8501609-f854-4f43-a51b-c6adf8126806_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data (PMID: 11939792): in Chinese hamster ovary cells (CHO-K1), led to impaired protein processing and trafficking and instability of encoded (mutant) ASB protein, leading to reduced levels of mature functional ASB in lysosomes ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d8501609-f854-4f43-a51b-c6adf8126806_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/89738f1c-762b-470f-8c7b-ea3155d181ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.629A>G (p.Tyr210Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114609"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1129c972-7493-4ddc-a536-86a38d10bf13","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","rdfs:label":"Patient 18","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f4fcfb7a-9b05-4e38-b70f-fb85ad55b01f"},{"id":"https://genegraph.clinicalgenome.org/r/89738f1c-762b-470f-8c7b-ea3155d181ea"}],"detectionMethod":"PCR followed by Sanger sequencing","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"ASB enzyme activity 0.3 pmol/min/mg, uGAG 43 ug/mgCr, ASB protein 2.4 ng/mg","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/205448fb-b63a-4c7f-b27e-32b0c5a3e5fa_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d8501609-f854-4f43-a51b-c6adf8126806_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/4001a12c-a1dc-415e-bada-94bb79373c82_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b80c0b1-711e-4c5d-806d-3d247daa6913","type":"EvidenceLine","dc:description":"Scored 1 total given ClinGen SVI recommendations for 1pt max for homozygous variants","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b80c0b1-711e-4c5d-806d-3d247daa6913_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1301949","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e5d162f-bd4a-4f4b-8502-2d73e45101d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.238del (p.Val80fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114604"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4001a12c-a1dc-415e-bada-94bb79373c82","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1301949","rdfs:label":"Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e5d162f-bd4a-4f4b-8502-2d73e45101d0"},"detectionMethod":"PCR done using cDNA","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Underwent biochemical testing for diagnosis for MPS6: deficient ASB enzyme activity in leukocytes and skin fibroblasts and normal activity of other sulfatase enzymes (iduronate- 2-sulfatase, a-L-iduronidase and P-D-glucuronidase); exact levels do not appear to be specified in the paper. ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b80c0b1-711e-4c5d-806d-3d247daa6913_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e386cdd1-7aa0-4311-b48e-cb5963802a0a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee769153-6d8f-48fa-b9cb-58ed4d22c3a7","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee769153-6d8f-48fa-b9cb-58ed4d22c3a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd33778d-03d0-4426-aec9-b696c612985f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.630_636del (p.Met209_Tyr210insTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559800"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ceeb58ae-5a76-4cfc-8555-7024eb6b8273","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ceeb58ae-5a76-4cfc-8555-7024eb6b8273_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/47519f9d-768b-46da-b1ae-d4e0fbe79dd6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.979C>T (p.Arg327Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559832"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e386cdd1-7aa0-4311-b48e-cb5963802a0a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","rdfs:label":"Patient 37","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bd33778d-03d0-4426-aec9-b696c612985f"},{"id":"https://genegraph.clinicalgenome.org/r/47519f9d-768b-46da-b1ae-d4e0fbe79dd6"}],"detectionMethod":"PCR amplification of cDNA followed by Sanger sequencing of exons 1-8 of ARSB gene","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"ASB enzyme activity 15pmol/min/mg and urinary GAG 683 ug/mg Creatinine ","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ceeb58ae-5a76-4cfc-8555-7024eb6b8273_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ee769153-6d8f-48fa-b9cb-58ed4d22c3a7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/65632503-5354-4c11-a624-97611cd04602_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04add3c6-4dcb-47c5-a31c-30bb6a07d24f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04add3c6-4dcb-47c5-a31c-30bb6a07d24f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 17161971): resulted in non-detectable levels of ASB protein and non-detectable ASB enzyme activity when expressed in chinese hamster ovary (CHO-KI) cells ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/04add3c6-4dcb-47c5-a31c-30bb6a07d24f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17161971","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc8925c5-f386-41fc-a686-cb537a9abfef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.944G>A (p.Arg315Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233482"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c0be2ff7-73ae-4552-98b6-72f3f2038d6b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0be2ff7-73ae-4552-98b6-72f3f2038d6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 17161971): resulted in non-detectable levels of ASB protein and non-detectable ASB enzyme activity when expressed in chinese hamster ovary (CHO-KI) cells ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c0be2ff7-73ae-4552-98b6-72f3f2038d6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17161971","allele":{"id":"https://genegraph.clinicalgenome.org/r/a43d619c-bd77-4a68-97a7-ae12fb6dcd10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.215T>G (p.Leu72Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559740"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/65632503-5354-4c11-a624-97611cd04602","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17161971","rdfs:label":"Patient 7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/fc8925c5-f386-41fc-a686-cb537a9abfef"},{"id":"https://genegraph.clinicalgenome.org/r/a43d619c-bd77-4a68-97a7-ae12fb6dcd10"}],"detectionMethod":"PCR amplification of cDNA followed by Sanger sequencing","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"ASB protein 0.24 ng/mg; ASB enzyme activity 0.13 pmol/min/mg, uGAG 342 ug/mgCr\n(Ranges: MPS VI D ND-6.0(n D 50), control 30–200 (n D 20). ARSB activity values (pmol/min/mg cell protein) are for cultured skin Wbroblasts against trisaccharide substrate; Range of ARSB activity: MPS VI D ND-2.4 (n D 42) control 11.8–39.4 (n D >60). Urinary GAG values for controls 10–60 gGAG/mg Creatinine (n D 46)\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/04add3c6-4dcb-47c5-a31c-30bb6a07d24f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c0be2ff7-73ae-4552-98b6-72f3f2038d6b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/909c65d4-53df-4974-945c-ae0ee172b578_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7818fbd-0421-47dd-adc8-96d6f2851be8","type":"EvidenceLine","dc:description":"Given counted as protein-truncating variant, deducted 0.5 per SVI guidelines for including RT-PCR analysis to confirm splice-site variants leading to protein-truncation and avoid double-counting functional evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7818fbd-0421-47dd-adc8-96d6f2851be8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17643332: shown via RT-PCR analysis to lead to skipping of exon 6, frameshift, and premature protein truncation, with NMD predicted ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c7818fbd-0421-47dd-adc8-96d6f2851be8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e2dcd27-b728-4d5e-816b-f6555632db62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000046.5(ARSB):c.1143-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114611"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/abc6625d-f0dd-4658-9e8f-f813f6bdf766","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abc6625d-f0dd-4658-9e8f-f813f6bdf766_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 17161971): resulted in non-detectable levels of ASB protein and non-detectable ASB enzyme activity when expressed in chinese hamster ovary (CHO-KI) cells ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/abc6625d-f0dd-4658-9e8f-f813f6bdf766_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","allele":{"id":"https://genegraph.clinicalgenome.org/r/a43d619c-bd77-4a68-97a7-ae12fb6dcd10"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/909c65d4-53df-4974-945c-ae0ee172b578","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17458871","rdfs:label":"Patient 99","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a43d619c-bd77-4a68-97a7-ae12fb6dcd10"},{"id":"https://genegraph.clinicalgenome.org/r/8e2dcd27-b728-4d5e-816b-f6555632db62"}],"detectionMethod":"PCR amplification of cDNA followed by Sanger sequencing","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"ASB enzyme activity undetectable; urinary GAG 526 ug/mgCr","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/abc6625d-f0dd-4658-9e8f-f813f6bdf766_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c7818fbd-0421-47dd-adc8-96d6f2851be8_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/b0d7229c-8211-4ed9-be14-4fdaa77338c1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf615cbb-4fd1-4748-a24b-1f0ade1fee3e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf615cbb-4fd1-4748-a24b-1f0ade1fee3e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Supporting functional data (PMID: 23557332): in COS-7 cells, resulted in reduced ASB enzymatic activity (<30% versus wild-type) and absence of mature ASB protein","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bf615cbb-4fd1-4748-a24b-1f0ade1fee3e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac760fd2-0543-48ff-9702-710c516e5036","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac760fd2-0543-48ff-9702-710c516e5036_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b0d7229c-8211-4ed9-be14-4fdaa77338c1"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9c55deb-ef73-41a7-a539-2c1adc4f58c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67056550-ce37-447b-9edf-d8cfefa42c13","type":"Finding","dc:description":"Phenotype recapitulates key features of MPS6, including dwarfism, facial dysmorphia, degenerative joint disease, corneal clouding, lysosomal inclusions in most tissues including chondrocytes and abnormal leukocyte inclusions. In addition, feline model shows approximately 0.3% of normal white blood cell ASB activities. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8910299","rdfs:label":"MPS6 feline model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/caaba159-2cad-48f7-ac5d-c8ea8998fe86","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f733f23d-f899-4632-8cf9-5fc8900b40e7","type":"Finding","dc:description":"As reviewed in PMID 17671068: 'Clinical trials in patients with MPS VI have addressed the safety and efficacy of ERT in the form of rhASB (Naglazyme, galsulfase).Efficacy and safety were evaluated in 39 patients with MPS VI in a randomized, double-blind, placebo-controlled, multicenter, multinational study for 24 weeks.The primary efficacy variable was the distance walked in a 12MWT, and the secondary efficacy variables were the number of stairs climbed in a 3MSC and the level of urinary glycosaminoglycan excretion. All patients received drug in a 24-week follow-on open-label extension period.37 \nFor the placebo-controlled portion of the study (weeks 1–24), the 19 patients who were receiving galsulfase (galsulfase group) showed a significantly greater improvement in the 12MWT than was observed in the 20 patients who were receiving a placebo (placebo group). For the 3MSC, those in the galsulfase group also demonstrated greater improvement after 24 weeks than was observed in those in the placebo group. After receiving galsulfase, all patients exhibited rapid declines in their urinary glycosaminoglycan level.'","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16647419","rdfs:label":"Enzyme replacement therapy - clinical trial","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2a850717-e21b-495d-8542-de4fdb142647_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59e5b6f5-5fc0-4e6a-8795-a60d0560c723","type":"EvidenceLine","dc:description":"Per Aminoacidopthy GCEP SOP, well-established associations are scored 2 points (see below):\n'Some of the gene products will have a well-established function in a metabolic pathway, supported by multiple studies over many years, and discussed in review papers. In that case, it is appropriate to cite the review and any figure(s) representing the role of the gene product in a metabolic pathway, and score 2 points. It is also recommended to score one or more primary research articles in addition to the review.'","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5edc47f6-402b-47a9-ab04-01edbb432324","type":"Finding","dc:description":"Accumulation of GAGs due to ASB deficiency results in mucopolysacchariduria. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20385007","rdfs:label":"ASB enzyme function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":4713,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ry2XioxKlCQ","type":"GeneValidityProposition","disease":"obo:MONDO_0009661","gene":"hgnc:714","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2a850717-e21b-495d-8542-de4fdb142647-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}